Stock Analysis·← Pickers

SXTC

China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc. (SXTC) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 59.2, with 1/3 trend checks passing.

Price
$2.58
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
59.2
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

SXTC with MA50 and MA200

300.0225.3150.775.981.3007/3110/2401/2204/1707/15
SXTC2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$2.00+29.30% vs price
MA200
$81.52-96.84% vs price
RSI (14)
59.2Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for SXTC

China SXT Pharmaceuticals, Inc. (SXTC) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $2.58, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 29.3% and below the 200-day moving average by 96.8%.

Momentum and stretch context

SXTC currently has an RSI reading of 59.2, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.

What traders may watch next

This page is designed to help you quickly understand what the SXTC chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Feng Zhou
Employees
56
Market cap
$1.8M
Beta
1.82
52-week range
$1.25 – $1047.00
Dividend
No
Exchange
NASDAQ
Country
CN
IPO date
4 Jan 2019
ISIN
VGG2161P1650
CUSIP
G2161P165
Company profile data from Financial Modeling Prep. SXTC listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about SXTC

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.